Podcasts about stroke prevention

Vascular neurologist Dr. Carolyn Brockington shares essential tips on how to prevent strokes and what to do if someone you know shows warning signs. Also, Craig visits a group of Atlanta dads transforming their local library into the neighborhood's go-to hangout spot. Plus, Mia Threapleton joins to talk about her role in the new Wes Anderson film ‘The Phoenician Scheme,' where she plays the daughter of a wealthy businessman. And, our Shop TODAY team rounds up great gift ideas for the graduate in your life.

Mike Sharma, MD, MSc, FRCPC - Can We Set a New Standard of Care for Secondary Stroke Prevention? Evaluating Current Gaps and Future Goals

Mike Sharma, MD, MSc, FRCPC - Can We Set a New Standard of Care for Secondary Stroke Prevention? Evaluating Current Gaps and Future Goals

Mike Sharma, MD, MSc, FRCPC - Can We Set a New Standard of Care for Secondary Stroke Prevention? Evaluating Current Gaps and Future Goals

Mike Sharma, MD, MSc, FRCPC - Can We Set a New Standard of Care for Secondary Stroke Prevention? Evaluating Current Gaps and Future Goals

Natto is a Superfood for Stroke Prevention, Blood Clot Reduction, and More! Looking for natural ways to boost your health? In this episode, I'm sharing the surprising benefits of natto—a traditional fermented soybean dish packed with powerful nutrients like nattokinase and vitamin K2. From preventing strokes and dissolving blood clots to potentially helping your body clear spike proteins post-COVID, natto is a sticky superfood with serious science behind it. I'll share how to enjoy it (even if the taste is new to you), how to make it yourself, and why this humble food has become a daily staple in my kitchen. Episode link:  https://www.culturedfoodlife.com/podcast/episode-314-natto-the-sticky-secret-to-health/ Link(s) I talked about: Article: https://www.culturedfoodlife.com/natto-superfood-for-stroke-prevention-blood-clot-reduction-and-more/ Check out these other links: My Story Video: https://youtu.be/CbX9Nv9OtGM For health tips and recipes, subscribe to our weekly emails. We'll also send you our free Getting Started Guide: http://bit.ly/2BnHpay Listen to all my podcasts: http://bit.ly/cflpodcast Become a Biotic Pro Member: http://bit.ly/2kkhwS1 Cultured Food Recipes: http://bit.ly/2UIfY2x Health and Food Topics: http://bit.ly/2SdzIOS My Amazon Shop: https://bit.ly/3KdhEge MY STARTER CULTURES Milk Kefir Grains: http://bit.ly/2rQ99PE L. Reuteri Superfood: https://bit.ly/LReuteriSuperfoodStarter L. Gasseri Superfood: https://bit.ly/LGasseriSuperfoodStarter Easy Kefir: http://bit.ly/2MQ1nPV Kefir Soda Starter: http://bit.ly/3YVErTa Kombucha Starter: http://bit.ly/2g2R9hE Vegetable Starter: http://bit.ly/2SzzVem Water Kefir Crystals:  http://bit.ly/2irmImW Sourdough Starter: http://bit.ly/2IjaaXK Other items in my store: http://bit.ly/2HTKZ27 STAY CONNECTED Instagram: http://instagram.com/culturedfoodlife/ Facebook: https://www.facebook.com/CulturedFoodLife/ Pinterest: http://pinterest.com/donnaschwenk/ Twitter: https://twitter.com/donnaschwenk

Do you know your “remnant cholesterol”? It could be better than LDL for predicting your risk of having a heart attack or stroke; Vagal nerve stimulation for seizures—could adding a keto diet help? Exoskeletons that help runners, hikers, and cyclists have hit the consumer marketplace for recreational athletes; RFK Jr's HHS launches program to improve infant formulas; Insurers bilk taxpayers for billions by double-charging Medicaid.

Chime In, Send Us a Text Message!Episode 81: Managing PFO after Stroke: A discussion on diagnosis, treatment options including the patient perspectives and quality of life decisions with David Thaler,MD of Tufts Medical Center.This conversation in collaboration with the SAYA Consortium explores the relationship between patent foramen ovale (PFO) and stroke, particularly in young adults. Our expert guest, Dr. David Thaler, a vascular neurologist with Tufts Medical Center, discusses the definition of PFO, its diagnosis, and its implications for stroke risk. The discussion highlights the importance of understanding cryptogenic strokes, which often have no identifiable cause, the PFO paradox and how a PFO is often discovered with cryptogenic strokes, the diagnostic tests and the management options available for patients with PFO. The conversation emphasizes the need for patient education and awareness regarding stroke risks and prevention strategies. In this conversation, Dr. Thaler discusses the implications of PFO closure in recurrent stroke prevention, medical management and the importance of patient choice and quality of life, plus the outcomes of the RESPECT Trial. Co-host David Dansereau shares his patient experience as a stroke survivor with PFO who elected for device closure.  The dialogue highlights the evolving landscape of PFO research and the significance of understanding individual patient risks and lifestyle choices.More About Our Guest: David Thaler,MD-Tufts Medical CenterShow mentions:  Lester Leung,MD,  Katelyn Skeels, SAYA Consortium, RESPECT Trial , Co-Host David's Book ClosureThanks to: Rory Polera (guest on Ep.69), stroke survivor and interview outline reviewer with SAYA ConsortiumAdditional Education: Support Our Show! Thank you for helping us to continue to make great content. We appreciate your generosity! Support the showShow credits:Music intro credit to Jake Dansereau. Our intro welcome is the voice of Caroline Goggin, a stroke survivor and our first podcast guest! Please listen to her inspiring story on Episode 2 of the podcast.Connect with Us and Share our Show on Social:Website | Linkedin | Twitter | YouTube | Facebook | SubstackKnow Stroke Podcast Disclaimer: Our podcast and media advertising services are for informational purposes only and do not constitute the practice of medical advice, diagnosis or treatment. Get Our Podcast News Updates on Substack

In this episode, Jonathan Sackier welcomes Andrew Southerland, a distinguished neurologist and academic leader in the field of vascular neurology. They explore how machine learning is revolutionising prehospital stroke diagnosis, and how innovative strategies like telemedicine can reduce disparities in stroke care.   Timestamps: (00:00) – Introduction (03:00) – Neurologic lessons from the wild turkey (05:10) – Linking COVID-19 and stroke (10:28) – How can AI revolutionise prehospital stroke diagnosis? (18:39) – Stroke management in underserved populations (23:38) – Google Glass in medical education (29:06) – What is the i-corps programme? (33:24) – Wearable devices as diagnostic tools (37:08) – Andrew's three wishes for healthcare

Dr. Bradley Stoner, Director of the Division of STD Prevention at the CDC, reports the findings in the latest STI Surveillance report; Katherine Feldman, Chief Performance Officer at the Maryland Department of Health, details the success of Maryland's State Health Improvement Plan; an ASTHO blog article outlines heart disease and stroke prevention in the pacific territories; and the Alabama Department of Public Health marks 150 years in existence. National Coalition of STD Directors Web Page: NCSD Congratulates Dr. Bradley Stoner on CDC Appointment; Applauds Leadership During STI Crisis CDC Web Page: Sexually Transmitted Infections Surveillance, 2023 Maryland Web Page: Building a Healthier Maryland ASTHO Blog Article: Maryland Achieves Success Through Thoughtful Planning ASTHO Blog Article: Heart Disease and Stroke Prevention in the Pacific Territories  

The Mayo Clinic used years of data from 600,000 patients to build an AI model that can detect and predict what doctors sometimes cannot. Dr. Guru Kowlgi, a cardiac electrophysiologist at the Clinic, joins us to discuss the complexity of data curation for AI modeling and how that curation is tied to trust.

When it comes to stroke patients, it's truly a race against the clock. Are you ready? Also, get ready to meet our two new co-hosts!  Join Eric, Sam, and Sydney as well as our two new co-hosts, Kellye' and Marcela, as they share their stories, experiences, and approaches for recognizing the symptoms and caring for stroke patients in a comprehensive and timely manner.    MEET OUR CO-HOSTS   Samantha Bayne, MSN, RN, CMSRN, NPD-BC is a nursing professional development practitioner in the inland northwest specializing in medical-surgical nursing. The first four years of her practice were spent bedside on a busy ortho/neuro unit where she found her passion for newly graduated RNs, interdisciplinary collaboration, and professional governance. Sam is an unwavering advocate for medical-surgical nursing as a specialty and enjoys helping nurses prepare for specialty certification.  Kellye' McRae, MSN-Ed, RN is a dedicated Med-Surg Staff Nurse and Unit Based Educator based in South Georgia, with 12 years of invaluable nursing experience. She is passionate about mentoring new nurses, sharing her clinical wisdom to empower the next generation of nurses. Kellye' excels in bedside teaching, blending hands-on training with compassionate patient care to ensure both nurses and patients thrive. Her commitment to education and excellence makes her a cornerstone of her healthcare team.   Marcela Salcedo, RN, BSN is a Floatpool nightshift nurse in the Chicagoland area, specializing in step-down and medical-surgical care. A member of AMSN and the Hektoen Nurses, she combines her passion for nursing with the healing power of the arts and humanities. As a mother of four, Marcela is reigniting her passion for nursing by embracing the chaos of caregiving, fostering personal growth, and building meaningful connections that inspire her work.   Eric Torres, ADN, RN, CMSRN is a California native that has always dreamed of seeing the World, and when that didn't work out, he set his sights on nursing.  Eric is beyond excited to be joining the AMSN podcast and having a chance to share his stories and experiences of being a bedside medical-surgical nurse.   Maritess M. Quinto, DNP, RN, NPD-BC, CMSRN is a clinical educator currently leading a team of educators who is passionately helping healthcare colleagues, especially newly graduate nurses. She was born and raised in the Philippines and immigrated to the United States with her family in Florida. Her family of seven (three girls and two boys with her husband who is also a Registered Nurse) loves to travel, especially to Disney World. She loves to share her experiences about parenting, travelling, and, of course, nursing!   Sydney Wall, RN, BSN, CMSRN has been a med surg nurse for 5 years. After graduating from the University of Rhode Island in 2019, Sydney commissioned into the Navy and began her nursing career working on a cardiac/telemetry unit in Bethesda, Maryland.  Currently she is stationed overseas, providing care for service members and their families.  During her free time, she enjoys martial arts and traveling. 

Another negative AF ablation trial, predicting AF after stroke, the value of RCTs, troponin testing in the ED and surgical aortic valve choice are the topics John Mandrola, MD, discusses this week. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I AF ablation Coronary Sinus Isolation for High-Burden Atrial Fibrillation: A Randomized Clinical Trial https://doi.org/10.1016/j.jacep.2024.09.017 Approaches to Catheter Ablation for Persistent Atrial Fibrillation (STAR AFII) https://www.nejm.org/doi/full/10.1056/NEJMoa1408288 Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial https://doi.org/10.1001/jama.2020.16195 Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical Trial https://www.ahajournals.org/doi/10.1161/CIRCEP.120.009288 II Post-Stroke AF monitoring Prediction of atrial fibrillation after a stroke event: a systematic review with meta-analysisMeta-analysis 10.1016/j.hrthm.2025.01.026 Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source https://www.nejm.org/doi/full/10.1056/NEJMoa1813959 Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source (Navigate ESUS https://www.nejm.org/doi/full/10.1056/NEJMoa1802686 Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy (ARCADIA) https://jamanetwork.com/journals/jama/fullarticle/2814933 III RCTs Large simple randomized controlled trials—from drugs to medical devices: lessons from recent experience https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-025-08724-x Outcomes 1 Year after Thrombus Aspiration for Myocardial Infarction (TASTE) https://www.nejm.org/doi/full/10.1056/NEJMoa1405707 IV Troponin Testing in the ED Cardiac Biomarker Testing in US Emergency Departments https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2829344 Updating Our Thinking on Troponin Use and Interpretation https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2777967 V Choice of AVR Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients 40-75 Years https://doi.org/10.1016/j.jacc.2025.01.013 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

“Active holistic therapy” for prostate cancer with diet and fish oil helps defer need for surgery, hormone blockade, radiation; Why 70 is the new 60; Long-term harmful effects of acid-blockers; Do memory supplements pass the blood-brain barrier? Fish oil, krill oil, olive oil for cardiovascular prevention; Paxlovid aggressively promoted but overprescribed for otherwise healthy patients. 

Chime In, Send Us a Text Message!In this episode of the Know Stroke Podcast, Rachel Forman, a stroke neurologist at Yale, discusses the latest American Stroke Association guidelines for stroke prevention. The conversation covers various topics including the importance of social determinants of health, dietary recommendations, exercise, blood pressure control, and the role of GLP-1 medications. Rachel emphasizes the need for individualized care and community engagement to effectively address stroke risks and improve patient outcomes. She also highlights the significance of mental health support for stroke survivors and the importance of awareness around gender-specific risks.TakeawaysSocial determinants of health are critical stroke risk factors.Exercise is essential for stroke prevention and recovery.Dietary changes should be realistic and gradual for patients.Blood pressure control is vital for preventing strokes.GLP-1 medications can aid in stroke prevention but should be combined with lifestyle changes.Women face unique stroke risks, especially during pregnancy.Community engagement is necessary for effective stroke prevention.Mental health support is crucial for stroke survivors.Healthcare providers must tailor recommendations to individual patient needs.Education and awareness are key in reducing stroke incidence.Support Our Show! Thank you for helping us to continue to make great content. We appreciate your generosity! Support the showShow credits:Music intro credit to Jake Dansereau. Our intro welcome is the voice of Caroline Goggin, a stroke survivor and our first podcast guest! Please listen to her inspiring story on Episode 2 of the podcast.Connect with Us and Share our Show on Social:Website | Linkedin | Twitter | YouTube | FacebookKnow Stroke Podcast Disclaimer: Our podcast and media advertising services are for informational purposes only and do not constitute the practice of medical advice, diagnosis or treatment.

In this episode, Dr. Valentin Fuster discusses the Garter AF trial, which evaluates the impact of screening for undiagnosed atrial fibrillation (AF) in older adults using a 14-day ECG monitor to reduce stroke risk. While the study found a marginal increase in AF diagnoses, it suggests that AI could play a crucial role in identifying high-risk patients who would benefit most from such screenings, highlighting the need for a more targeted approach in future trials.

Ryan Gorman hosts an iHeartRadio nationwide special featuring Theresa Wolters, Vice President of Health & Human Services at MusiCares, who joins the show to discuss how MusiCares provides various services for musicians and those in the music industry facing financial hardship. Also, Dr. Jessica Lee, acting chief medical officer at the Center for Medicaid & CHIP Services at the Center for Medicare and Medicaid Services, checks in to explain healthcare options and coverage for children in low-income households. Finally, Dr. Janet S. Wright, Director of the CDC's Division for Heart Disease & Stroke Prevention, offers vital information about heart valve disease, from an overview of the condition to signs, symptoms, and a breakdown of those most at risk.

Heart valve disease affects more than 5 million people in the U.S. and leads to 25,000 deaths each year. Aortic stenosis, the most common form of heart valve disease, affects 5% of people 65 and older. Heart valve symptoms may be subtle and develop slowly over time, putting a life-threatening strain on your heart. Early diagnosis of heart valve disease is key says Janet S. Wright, MD, FACC, Director of CDC's Division for Heart Disease and Stroke Prevention. Learn signs and how to reduce risk.Fearless Fabulous You is broadcast live Wednesdays at 12 Noon ET on W4WN Radio - Women 4 Women Network (www.w4wn.com) part of Talk 4 Radio (www.talk4radio.com) on the Talk 4 Media Network (www.talk4media.com). Fearless Fabulous You Podcast is also available on Talk 4 Media (www.talk4media.com), Talk 4 Podcasting (www.talk4podcasting.com), iHeartRadio, Amazon Music, Pandora, Spotify, Audible, and over 100 other podcast outlets.

Xiaoxi Yao, MPH, MS, PhD, FACC, JACC Associate Editor, interviews Renato Lopes, MD, PhD, FACC, author of the GUARD-AF trial published in JACC and presented at ESC Congress 2024.

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome back to "Ditch the Lab Coat," the podcast where we explore the fascinating world of health and medicine with a skeptical eye. I'm Dr. Mark Bonta and In today's episode, Dr. Kaplovitch dives deep into the different types of blood clots and the importance of personalized treatment. He explains that not all blood clots are created equal - some predominantly affect the veins, while others can travel to the lungs and become life-threatening. We discuss the various risk factors that can lead to blood clot formation, from genetic conditions to long plane rides, and Dr. Kaplovitch offers practical advice on managing this complex disorder.We also touch on the fascinating history behind some blood thinning medications, like warfarin, which was originally used as rat poison! Dr. Kaplovitch clarifies the distinctions between its toxic properties and medical use. Throughout our conversation, we emphasize the importance of transparently counseling patients about the risks and benefits of different treatments. Dr. Kaplovitch highlights the abundance of research in the field of thrombosis and how it informs the personalized approach he takes with his patients.So join us as we simplify these complex medical concepts and explore the latest advancements in blood clot prevention and treatment. As always, remember that this podcast is for informational purposes only and does not substitute for professional medical advice. Let's ditch the lab coat and dive in!04:24 Experienced medical student impresses with professionalism.09:02 Blood clots can travel to lungs, fatal.12:14 Prolonged sitting at desk may increase thrombosis risk.16:01 Minority with blood clots can improve naturally.18:45 Clot busters have significant risk of bleeding.20:59 Treatment options for preventing blood clot complications.25:39 Passion for vascular medicine, citing primary literature.29:26 Newer blood thinners may have advantages.31:37 Warfarin inhibits clotting by blocking vitamin K.36:09 Balancing blood thinness for health benefits is crucial.37:22 Maintain optimal blood thinness to prevent risks.42:22 Minor bleeding from gut might not require action.46:27 Consistent blood thinner use is crucial.50:05 Discussing evolving thrombosis practices, specifically genetic testing controversies.51:24 Testing for clotting disorders requires informed discussion.57:02 Advancements in personalized medicine revolutionize treatment.58:45 Hip hop slang reference and deep thrombosis.

This week on The Beat, Editor in Chief Joel Dunning discusses the implementation of the Versius robotic surgical system for thoracic surgery and summarizes the ability of the Versius surgical system to successfully and safely complete a range of thoracic procedures aligned with phase 2a of the (Development) of the Idea, Development, Exploration, Assessment and Long-term follow-up (IDEAL) framework for surgical innovation.   He also discusses the perioperative tools to predict neurocognitive outcomes in congenital heart surgery, the differences in right heart function after pulmonary valve replacement in patients with pulmonary valve stenosis versus tetralogy of Fallot, and the left atrial appendage closure for stroke prevention in atrial fibrillation.  In addition, Joel discusses neoarotic valve repair with a subannular ring for complex trileaflet prolapse after an arterial switch operation, the use of the autologous innominate vein as a substitute for the pulmonary arteries, and another installment in Dr. Tristan Yan's aortic repair series focused on the technical details of the mini-access David procedure. Before saying goodbye, Joel discusses upcoming events in CT surgery.  JANS Items Mentioned Implementation of the Versius Robotic Surgical System for Thoracic Surgery: First Clinical Evaluation of Feasibility and Performance  Perioperative Tools to Predict Neurocognitive Outcome in Congenital Heart Surgery  Differences in Right Heart Function After Pulmonary Valve Replacement in Patients With Pulmonary Valve Stenosis Versus Tetralogy of Fallot  Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation: Current Status and Perspectives  CTSNet Content  Neoaortic Valve Repair With a Subannular Ring for Complex Trileaflet Prolapse After an Arterial Switch Operation  Deep Dive Into Aortic Surgery: Mini-Access David Procedure—Endoscopic Assessment of Valve Competency   The Use of the Autologous Innominate Vein as a Substitute for the Pulmonary Arteries in Pulmonary Atresia and Absent PAs  Other Items Mentioned CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Please visit answersincme.com/XFG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in vascular neurology discusses the data and the implications for inhibiting coagulation factor XIa (FXIa) as a therapeutic option in stroke prevention. Upon completion of this activity, participants should be better able to: Identify the rationale for inhibiting FXIa as a therapeutic option in stroke prevention; Describe the latest clinical data for oral FXIa inhibitors in stroke prevention; and Review the implications of the latest FXIa inhibitor data for the future of stroke prevention.

David Cohen is one of the smartest docs on Twitter. I learned a bunch talking with him. The procedure called transcatheter aortic valve implantation or TAVR is a damn miracle. In days of old, a heart surgeon would have to saw open the chest and cut out the heavily calcified immobile aortic valve and sew in a new one. I watched a case as a young doctor and came away shocked that patients survive this surgery. TAVR is even more stunning. Doctors place a valve up the aorta, across the diseased valve, and then place the new valve into the old valve. The verbs squishing or smooshing come to mind. The other unbelievable thing about TAVR is that strokes are less common than you'd think. When I first heard about TAVR, I thought: how is it not limited by all that debris going into the brain? Well, there is less debris than I would have thought. But not zero debris. In fact, there is one device on the market that forms a barrier between the aorta and the brain. We call it an embolic protection device (EPD) or cerebral embolic protection (CEP).Early studies show that the device catches debris that would have occluded blood vessels in the brain—iow, caused stroke. The pictures almost sell the device—because, obviously, catching debris has to be beneficial. But. But. There are always ‘but's' in Medicine. The PROTECTED TAVR trial, which compared TAVR with and without an embolic protection device failed to show a statistically significant reduction in stroke. It was a good trial, but it did not close the door for the device. For two reasons: one was that the trial was underpowered. The lower bound of the 95% confidence interval allowed for a 1.7% lower rate of stroke in the treatment arm. Neurologists feel that a 1% risk reduction in stroke is clinically important. The other reason was that a secondary endpoint of “disabling” stroke was 60% lower with the device. We needed more data. Another trial is not likely going to happen. Trials are expensive and take a long time. This is where Dr Cohen's group comes in. They performed an observational study looking at more than 400k patients in a TAVR registry. About 13% got the device and 87% did not. This is where Sensible Medicine readers should start feeling a rash. Why? Because you know how scary it is to try and compare outcomes in two groups of patients who were not randomized. Cohen, however, tells me about a super-interesting way to approximate randomization in this comparison. It's called an instrumental variable analysis. He explains this to me in clear terms during our conversation. I love methods so I was enthralled. But that isn't all. The other thing is that his study, like the PROTECTED TAVR trial, came up with tantalizing close results. We discuss that as well. I loved our talk. If you like evidence, methods, and great medical stories, I think you will also like this conversation. JMMIt's free to all. We appreciate your support for this experiment in bringing ad-free medical information to the public. Sensible Medicine is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

Braydon Dymm, MD, is a board-certified neurologist and accomplished physician who specializes in cerebrovascular disease and stroke care.After graduating summa cum laude from the University of Detroit Mercy and earning his medical degree from Wayne State University School of Medicine, he completed his neurology residency at Michigan Medicine. Dr. Dymm recently finished an advanced fellowship in cerebrovascular neurology at Duke University Hospital. He has made significant research contributions with publications in respected journals like Neurology and Stroke. Currently, Dr. Dymm serves as a neurohospitalist in the Department of Neurology at Charleston Area Medical Center.His passion for advancing stroke care and medical education has established him as an emerging leader in the field. In this episode, we cover:The differences between ischemic and hemorrhagic strokes, including causes and symptoms.The critical of recognizing stroke symptoms quickly using the BFAST mnemonic.Gender disparities in stroke incidence, with a focus on why women are more affected and have worse outcomes.The role of high blood pressure and cholesterol in stroke risk and prevention strategies.The effectiveness of exercise, diet, and stress management in reducing stroke risk.Advances in stroke treatment, including the transition from TPA to tenecteplase for quicker administration.The potential for new technologies, like continuous blood pressure monitors, to improve stroke prevention.Sign up to The Neuro Athletics Newsletter: https://bit.ly/3ewI5P0Connect with BraydonTwitter: https://x.com/BraydonDymmMy Socials:Instagram: https://www.instagram.com/louisanicola_/Twitter : https://twitter.com/louisanicola_Sponsors for today's episode:Momentous - Use code NEURO to get 20%  off your first subscription order - code NEURO:  https://www.livemomentous.com/Inside Tracker - Use code LOUISA20 for 20% off - https://insidetracker.com/louisaZocDoc- Use code NEURO - https://www.zocdoc.com/neuro(00:00) Preview and Intro(00:36) Introducing Dr. Braydon Dymm(01:08) Gender Disparities in Stroke?(02:28) Pathology of Ischemic Stroke(06:29) Small Vessel Strokes(09:56) Alzheimer's as Vascular Dementia(11:18) Managing Blood Pressure and Cholesterol(13:15) Role of Exercise in Stroke Prevention(14:22) Resistance Training and Dementia Prevention(18:13) Golden Hour in Stroke Treatment(20:07) Recognizing Stroke Symptoms with BFAST(24:47) Anticoagulants vs. Antiplatelets(25:56) Preventing Strokes with Blood Thinners(26:45) Hemorrhagic Strokes(29:36) Medication Differences for Stroke Types(32:58) Gender Differences in Stroke Outcomes(33:04) Challenges of DeThe Neuro Athletics Newsletter Instagram: @louisanicola_Twitter : @louisanicola_YouTube: @Louisa NicolaThe Neuro Experience Podcast is proud to have hosted: Dr Andrew Huberman, Dr Gabrielle Lyon, Dr Layne Norton, Thomas DeLauer, Shawn Stevenson, Dr. Rocio Salas-Whalen, Saad Alam, Uma Naidoo, Dr. Lanna Cheuck, Angela Lee Pucci, Jillian Turecki, Dr. Jordan Feigenbaum, Dr. Darren Candow, Dr. Sue Varma, Evy Poumpouras, Dr Casey Means, Renee Deehan, Dr Chris Palmer, Dr Charles Brenner.

A stroke happens when there is a sudden blockage of blood flow to the brain or bleeding in the brain, which can result in symptoms such as numbness or weakness, trouble speaking, confusion, or dizziness. The type of symptoms one might experience depends largely on the type of stroke, and the area of the brain affected. But one thing is clear – despite the many advances in stroke care over the past 30 years, it's women who often suffer the most.  In today's episode, we discuss why women are more susceptible to stroke, what the unique risk factors are, and what women need more of to help them recover, not only from the medical condition, but the impacts to their careers, their mental health and their families. Featuring: Dr. Aleksandra Pikula, MD, PhD, is a neurologist and clinician-investigator at UHN's Krembil Brain Institute and the newly appointed Jay and Sari Sonshine Chair in Stroke Prevention and Cerebrovascular Brain Health at UHN. Dr. Pikula advocates for a holistic approach to brain care, specifically targeting stroke and dementia prevention during midlife through evidence-based lifestyle medicine pillars.Patrice Lindsay, PhD, is currently the Lead for the People With Lived Experience (PWLE) Engagement and Stroke Strategy at the Heart and Stroke Foundation of Canada. Dr. Lindsay leads strategic directions for health systems design and change for people with stroke and heart conditions across Canada and internationally. Shruti Kothari is an actress born, raised, and residing in Toronto. Her career was focused largely on Shakespeare and Musical Theatre until her life took an unexpected turn when she suffered a life-altering brain hemorrhage and stroke at the age of 30. Over the past four years, Shruti has focused on reshaping her life and raising awareness about brain injuries in younger people. Additional resources: UHN's Stroke Prevention ClinicDr. Pikula interviewed in the Your Complex Brain episode “The Rise of Stroke in Young Adults”UHN Foundation video “Shruti's journey back to the stage, with some help from Team UHN”Heart and Stroke Foundation of Canada – Women's Digital HubWorld Stroke Academy pThe Your Complex Brain production team is Heather Sherman, Jessica Schmidt, Dr. Amy Ma, Kim Perry, Sara Yuan, Meagan Anderi, Liz Chapman, and Lorna Gilfedder.The Krembil Brain Institute, part of University Health Network, in Toronto, is home to one of the world's largest and most comprehensive teams of physicians and scientists uniquely working hand-in-hand to prevent and confront problems of the brain and spine, such as Parkinson's, Alzheimer's, epilepsy, stroke, spinal cord injury, chronic pain, brain cancer or concussion, in their lifetime. Through state-of-the-art patient care and advanced research, we are working relentlessly toward finding new treatments and cures.Do you want to know more about the Krembil Brain Institute at UHN? Visit us at: uhn.ca/krembilTo get in touch, email us at krembil@uhn.ca or message us on social media:Instagram - @krembilresearchTwitter - @KBI_UHNFacebook - https://www.facebook.com/KrembilBrainInstituteThanks for listening!

Uncover essential strategies for stroke prevention, including risk management, healthy lifestyle choices, and early detection signs. In this podcast, Shellee Stine, RN, the Clinical Program Coordinator for the Primary Stroke Center at the University of Maryland Charles Regional Medical Center, gives expert guidance on fortifying your health against strokes for a brighter tomorrow.

KSQD 4-24-2024: In this week's show, we tackle several important health topics. Dr. Dawn starts by investigating "the prescribing cascade," where side effects from an initial medication necessitate additional prescriptions. This is often seen with treatments for high blood pressure and atrial fibrillation. We then explore strokes of undetermined origin. Interestingly, Dr. Dawn notes that for preventing recurrent strokes, the classic, low-cost aspirin can be just as effective as newer, more expensive alternatives. Another topic is delayed orthostatic hypotension, a condition where blood pressure drops upon standing. Dr. Dawn provides details on a simple test for diagnosis. We address a worrying trend: increasingly aggressive colon cancers are occurring in younger populations. Dr. Dawn discusses both established and novel screening tests, like the new DNA-based successor to Cologuard, emphasizing the importance of early detection. Finally, we offer a sobering reality check about vaping. Studies show a growing number of young people who begin with vaping are transitioning to traditional smoking, underscoring that vaping carries its own significant risks.

On Episode 39 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the April 2024 issue of Stroke: “Intravenous Tirofiban Versus Alteplase Before Endovascular Treatment in Acute Ischemic Stroke: A Pooled Analysis of the DEVT and RESCUE BT Trials” and “Radial Versus Femoral Access for Mechanical Thrombectomy in Stroke Patients: A Non-Inferiority Randomized Clinical Trial.” She also interviews Dr. Shadi Yaghi about his article “Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study.” For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20240401.480865

Intermittent fasting, anticoagulation decisions, heterogenous treatment effects, frailty in HF, the importance of the ECG, and industry conflicts are the topics John Mandrola, MD, covers this week. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Intermittent Fasting No, Intermittent Fasting Won't Kill You https://www.medscape.com/viewarticle/1000544 NEJM Paper on Time-Restricted Eating  https://www.nejm.org/doi/full/10.1056/NEJMoa2114833 JAMA TREAT Clinical Trial https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2771095 II. Stroke Prevention with OAC Shah Meta analysis of Vitamin K Agonists in AF https://www.ahajournals.org/doi/abs/10.1161/CIRCOUTCOMES.123.010269 III. Heterogenous Treatment Effects in Trials Pivotal CV Trials May Not Apply to Complex Patients https://www.medscape.com/viewarticle/989129 Analysis of 8 Trials of Multimorbidity and Treatment Response https://doi.org/10.1016/j.amjmed.2024.01.028 IV. Frailty and HF Circulation Outcomes: Multidomain Frailty and Mode of Death in HF  https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.123.010416 V. ECG in LBBB JAMA Cardiology: Revised Definition of LBBB  https://jamanetwork.com/journals/jamacardiology/fullarticle/2816973 VI. Industry Payments to Doctors JAMA: Payments to US Physicians by Specialty https://jamanetwork.com/journals/jama/fullarticle/2816900 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week, please join author William McIntyre, Editorialist Christian Ruff, and Associate Editor Shinya Goto as they discuss the article "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials." For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20240322.70604

Dr. Marcus Plescia, ASTHO Chief Medical Officer, tells us ASTHO continues to focus on improving heart health in our island areas; Lisa Peterson, ASTHO Senior Director for Preparedness, discusses the upcoming 2024 Preparedness Summit; and an ASTHO report highlights successful partnerships between state health agencies and transportation sectors to address health disparities in accessing care. ASTHO Blog Article: Heart Disease and Stroke Prevention in the Pacific Territories 2024 Preparedness Summit Webpage ASTHO Report: Braiding and Layering Funding to Address the Social Determinants of Health

Electrophysiologist Dr. Richard Jones, of the MedStar Heart and Vascular Institute, talks about symptoms and treatment for the full spectrum of the most common form of cardiac arrythmia: atrial fibrillation.  Are you feeling a flutter in your chest, or maybe your smartwatch is signaling an irregular heartbeat? It's time to tune in to your heart's health because atrial fibrillation (AFib) is not just a condition for the textbooks—it's a growing concern for millions. In the latest episode of 'MedStarHealth Doc Talk,' we sit down with Dr. Richard Jones, an electrophysiologist from the MedStar Heart and Vascular Institute, to delve into the intricacies of AFib. With a projected 30% increase in cases every two decades, understanding AFib has never been more critical. AFib is the most common type of serious heart rhythm abnormality in adults. When the heart's upper chambers quiver chaotically, they fail to pump blood effectively, leading to symptoms like palpitations, fatigue, and potentially life-threatening strokes. But what's more alarming is that some individuals with AFib might not feel any symptoms at all, making them ticking time bombs for stroke risks. Dr. Jones explains how new guidelines by the American College of Cardiology and the American Heart Association are categorizing AFib and recommending best practices for treatment. These guidelines emphasize the importance of early intervention and the role of lifestyle changes in managing AFib. The episode also highlights the latest advancements in treatment, such as catheter ablation—a procedure that targets the heart's electrical misfires to prevent AFib episodes. Dr. Jones shares that while this isn't a cure, it's a significant step forward in managing the condition and improving quality of life.For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Left Atrial Appendage Occlusion or Anticoagulation for Stroke Prevention in A Fib Guest: Mohamad Adnan (Mohamad) Alkhouli, M.D. Hosts: Malcolm R. Bell, M.D. In this podcast, we will discuss LAAO as an emerging method to reduce stroke risk in patients with atrial fibrillation. We will talk about the current advances and the remaining questions in the LAAO space.   Topics Discussed: Atrial fibrillation and blood thinners What is LAAO? LAAO vs. anticoagulation Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

Nearly 800,000 Americans have a stroke each year, so make sure you know how to help if your loved one has a sudden attack. Our experts give you the tools to know the signs, symptoms, and actions you can take to save a life. Remember to BE FAST, every minute matters. Learn More: https://radiohealthjournal.org/minute-by-minute-everything-you-need-to-know-about-stroke-prevention Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023. Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London. Drs Kalra and Nijjer share their perspectives and experiences, offering valuable insights, practical tips and considerations when interpreting this year's most impactful trials: • ORBITA-2 (AHA Scientific Sessions): PCI for stable angina • FIRE (ESC Congress): Functional versus culprit-only revascularization in elderly patients with myocardial infarction and multivessel disease • DAPA-MI (AHA Scientific Sessions): SGLT2i in MI without diabetes or heart failure • ILUMIEN IV (ESC Congress): OCT vs angiography-guided PCI • OCTOBER (ESC Congress): OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions • ARTESIA (ESC Congress): Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation • SELECT (AHA Scientific Sessions): Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes What are the most impactful cardiovascular trials of 2023? How do Dr Kalra and Dr Nijjer integrate the latest information into their daily practices?

There are a number of risks for strokes, some modifiable. Advancements in treatment have saved countless lives. David Stone, MD, a vascular neurologist at Sarasota Memorial discusses what can be done to prevent strokes and what it means for SMH-Sarasota to be a recognized Comprehensive Stroke Center.You can also watch the video recording on our Vimeo channel here.For more health tips & news you can use from experts you trust, sign up for Sarasota Memorial's monthly digital newsletter, Healthe-Matters.

Janice Y. Chyou, MD, FHRS, of Icahn School of Medicine at Mount Sinai is joined by guests Jonathan P. Piccini, Sr., MD, MHS, FHRS, of Duke University Medical Center, and Mintu P.Turakhia, MD, MS, of iRhythm Technologies and Stanford University to have A Discussion of Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. Subclinical atrial fibrillation is associated with an increased risk of stroke by a factor of 2.5; however, treatment with oral anticoagulation is of uncertain benefit. Among patients with subclinical atrial fibrillation, apixaban resulted in a lower risk of stroke or systemic embolism than aspirin but a higher risk of major bleeding.   https://www.hrsonline.org/education/TheLead https://www.nejm.org/doi/full/10.1056/NEJMoa2310234   Host Disclosure(s): J. Chyou: Honoraria/Speaking/Consulting Fee: McGraw-Hill, American Heart Association; Membership (Advisory Committee): American Heart Association   Contributor Disclosure(s): J. Piccini: Honoraria/Speaking/Consulting Fee: Biotronik, AbbVie, LivaNova, Boston Scientific, Phillips, Medtronic, Electrophysiology Frontiers, Abbott, UpToDate, Inc., Sanofi, Milestone Pharmaceuticals, Bayer Healthcare Pharmaceuticals; Research (Contracted Grants for PIs Named Investigators Only): Boston Scientific, Bayer Healthcare Pharmaceuticals, AMA, Abbott, Phillips, Element Science, Inc., iRhythm Technologies, NIH   M. Turakhia: Research (Contracted Grants for PIs Named Investigators Only): Bristol-Myers Squibb, FDA Circulatory System Devices Panel, American Heart Association, Bayer Healthcare Pharmaceuticals, Sanofi; Stocks (Board Membership): 100Plus; Employment: iRhythm Technologies

AHA23 Congress Coverage: Apixaban in subclinical AF (ARTESIA)

MedLink Neurology Podcast is delighted to feature selected episodes from BrainWaves, courtesy of James E Siegler MD, its originator and host. BrainWaves is an academic audio podcast whose mission is to educate medical providers through clinical cases and topical reviews in neurology, medicine, and the humanities, and episodes originally aired from 2016 to 2021. Originally released: July 18, 2017 Long-term antithrombotic treatment of embolic stroke sounds like a tricky field to navigate. Aspirin is the drug of choice in the acute setting for most patients, but when cardioembolic stroke is suspected, aspirin is inferior to anticoagulation for preventing recurrent stroke. In the age of novel oral anticoagulants, why choose warfarin and risk drug interactions, dietary restrictions, and bleeding risk? In this episode, we discuss the pros and cons of each of the major NOACs for secondary stroke prevention. Enjoy! BrainWaves podcasts and online content are intended for medical education only and should not be used to guide medical decision-making in routine clinical practice. Any cases discussed in this episode are fictional and do not contain any patient health-identifying information. REFERENCES Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139-51. Erratum in: N Engl J Med 2010;363(19):1877. PMID 19717844Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013;369(22):2093-104. PMID 24251359Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365(11):981-92. PMID 21870978Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365(10):883-91. PMID 21830957 We believe that the principles expressed or implied in the podcast remain valid, but certain details may be superseded by evolving knowledge since the episode's original release date.

Preventing Heart Disease And Stroke With Diet And Lifestyle In this compelling video, renowned experts Drs. Anthony Lim, Kim Williams, and Steven Lome delve into the role of diet and lifestyle in preventing heart disease and stroke. From the potential of plant-based nutrition to the underestimated role of stress management, they offer expert insights to help you lead a heart-healthy life. Gain an in-depth understanding of how lifestyle changes can prevent and even reverse heart disease. Join us on this transformative journey towards optimum health. Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

What Not To Eat For Stroke Prevention by Dr. Michael Greger at NutritionFacts.org   Original post: https://nutritionfacts.org/video/what-not-to-eat-for-stroke-prevention/   Related Episodes: 338: A Life-Threatening Stroke Spurred Me to Try a Plant-Based Diet, and I've Never Looked Back 506: After a Stroke, This Doctor Reversed Her Lupus With a Plant-Based Diet 517: A Game-Changing Solution to One of the Most Devastating Diseases of the Brain: Stroke 608: Understanding Types of Strokes and How to Prevent Them   Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity.   How to support the podcast: Share with others. Recommend the podcast on your social media. Follow/subscribe to the show wherever you listen. Buy some vegan/plant based merch: https://www.plantbasedbriefing.com/shop    Follow Plant Based Briefing on social media: Twitter: @PlantBasedBrief YouTube: YouTube.com/PlantBasedBriefing  Facebook: Facebook.com/PlantBasedBriefing  LinkedIn: Plant Based Briefing Podcast Instagram: @PlantBasedBriefing   #vegan #plantbased #Plantbasednutrition #plantbasedbriefing #stroke #strokeprevention      

Editor's Summary by Karen E. Lasser, MD, MPH, Senior Editor of JAMA, the Journal of the American Medical Association, for the August 22/29, 2023, issue. Related Content: Audio Highlights

Host: Josie Bidwell, Associate Professor of Preventive Medicine and Nurse Practitioner at the University of Mississippi Medical Center.Guest(s): Dr. Kunal Bhatia, Assistant Professor of Neurology at the University of Mississippi Medical CenterTopic: Strokes - Heat Stroke; Stroke Prevention; Stroke Warning Signs; B.E. F.A.S.T. (Balance, Eyes, Face, Arms, Speech, Time); Ministroke or T.I.A. (Transient Inschemic Attack)Email: fit@mpbonline.org. Hosted on Acast. See acast.com/privacy for more information.

Today, we're debunking longstanding myths about health and aging with my guest Jeffrey Gladden, a true expert in longevity and vibrant living. Join us for an eye-opening conversation that will challenge your beliefs and inspire you to live young for a lifetime. Meet Jeffrey Gladden:Dr. Jeffrey Gladden is a Board certified interventional cardiologist and the founder of Gladden Longevity, Human Performance & Longevity Optimization. He did his undergraduate work at Wheaton College and earned his Doctor of Medicine degree with Honors from Temple University in 1982. He has specialized in many areas of cardiology, including interventional, diagnostic, preventative and programmatic.Dr. Gladden is currently the Director of Heart Attack and Stroke Prevention and Cardiac Rehabilitation at The Heart Hospital Baylor Plano, which he co-founded in 2004. He is CEO Board Chair, Principle and CMO for Product Development at Scientia Cardio Access and a board member at Scientia Vascular. He is currently licensed in three states, his work is published in multiple medical journals, and he is a consultant for multiple cardiovascular projects, programs and medical device development.Connect with Jeffrey:Website: https://www.gladdenlongevity.com/Podcast: https://gladdenlongevitypodcast.com/Meet Loral Langemeier:Loral Langemeier is a money expert, sought-after speaker, entrepreneurial thought leader, and best-selling author of five books.Her goal: to change the conversations people have about money worldwide and empower people to become millionaires.The CEO and Founder of Live Out Loud, Inc. – a multinational organization — Loral relentlessly and candidly shares her best advice without hesitation or apology. What sets her apart from other wealth experts is her innate ability to recognize and acknowledge the skills & talents of people, inspiring them to generate wealth.She has created, nurtured, and perfected a 3-5 year strategy to make millions for the “Average Jill and Joe.” To date, she and her team have served thousands of individuals worldwide and created hundreds of millionaires through wealth-building education keynotes, workshops, products, events, programs, and coaching services.Loral is truly dedicated to helping men and women, from all walks of life, to become millionaires AND be able to enjoy time with their families.She is living proof that anyone can have the life of their dreams through hard work, persistence, and getting things done in the face of opposition. As a single mother of two children, she is redefining the possibility for women to have it all and raise their children in an entrepreneurial and financially literate environment. Links and Resources:Ask Loral App: https://apple.co/3eIgGcXLoral on Facebook: https://www.facebook.com/askloral/Loral on YouTube: https://www.youtube.com/user/lorallive/videosLoral on LinkedIn: https://www.linkedin.com/in/lorallangemeier/Money Rules: https://integratedwealthsystems.com/money-rules/Millionaire Maker Store:

Full article: https://www.ajronline.org/doi/10.2214/AJR.23.29352  Transient ischemic attacks (TIAs) are very common in the United States, and prompt diagnosis of TIAs is important as they are associated with an increased risk of subsequent stroke. Jesi Kim, MD provides a discussion and critical analysis of an important article that demonstrates increased odds of subsequent stroke in patients who had incomplete neurovascular imaging after an emergency department encounter for TIA.

In this episode of the Better Edge podcast, Bradley P. Knight, MD, director, Cardiac Electrophysiology, director, Center for Heart Rhythm Disorders and the Chester C. and Deborah M. Cooley Distinguished Professor of Cardiology at Northwestern Medicine, discusses the intricacies of safely and effectively implanting LAAO devices for stroke prevention in patients with atrial fibrillation. He talks about the criteria for determining whether a LAAO device is optimal for a patient and his greatest clinical challenge as a cardiac electrophysiologist when placing this closure device.

Keeping the conversation going during Stroke Awareness Month, this week we welcome neurologist and medical director of the McLaren Stroke Program in Flint, Michigan, Dr. Sunita Tummala, MD, to FOX Rehabilitation's Live Better Longer podcast. Dr. Tummala takes us through her early career and why she chose neurology and then details the work she currently performs for patients who have had a stroke, including how to best serve them during the recovery process and the benefits of receiving physical, occupational, or speech-language pathology. Dr. Tummala sheds light on the critical significance of prompt symptom recognition and immediate action in the case of strokes, which remain among the leading causes of death in the U.S. Since Dr. Tummala is also a music fanatic, we end this week's episode by talking about The Beatles, Bono, and music therapy's top song—which may surprise you.

Keeping the conversation going during Stroke Awareness Month, this week we welcome neurologist and medical director of the McLaren Stroke Program in Flint, Michigan, Dr. Sunita Tummala, MD, to FOX Rehabilitation's Live Better Longer podcast. Dr. Tummala takes us through her early career and why she chose neurology and then details the work she currently performs for patients who have had a stroke, including how to best serve them during the recovery process and the benefits of receiving physical, occupational, or speech-language pathology. Dr. Tummala sheds light on the critical significance of prompt symptom recognition and immediate action in the case of strokes, which remain among the leading causes of death in the U.S. Since Dr. Tummala is also a music fanatic, we end this week's episode by talking about The Beatles, Bono, and music therapy's top song—which may surprise you.

On Episode 28 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the May 2023 issue of Stroke: “Decreased Estimated Glomerular Filtration Rate and Proteinuria and Long-Term Outcomes After Ischemic Stroke: A Longitudinal Observational Cohort Study” and “Stroke Prevention and Treatment in People With Type 2 Diabetes: Is There a Role for GLP-1 (Glucagon-Like Peptide-1) Analogues?” She also interviews Drs. Kanishk Kaushik and Marieke J.H. Wermer about their article “Iatrogenic Cerebral Amyloid Angiopathy Post Neurosurgery: Frequency, Clinical Profile, Radiological Features, and Outcome.” For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20230501.274417  

CardioNerds Amit Goyal, Dr. Colin Blumenthal, Dr. Kelly Arps and Dr. Justice Oranefo discuss mechanical stroke prevention in atrial fibrillation with Dr. Christopher Ellis, cardiac electrophysiology lab director and director of the left atrial appendage closure program at Vanderbilt University. There has been a significant increase in the number of patients undergoing left atrial appendage occlusion (LAAO). This trend is expected to continue with current and upcoming clinical data on this topic. In this episode we dive into the rationale behind LAAO and explore several historical facts. We then proceed to the current state of practice including currently available options, appropriate indications, post op care, and potential complications. Notes were drafted by Dr. Justice Oranefo. Audio editing by CardioNerds Academy Intern, student doctor Chelsea Amo Tweneboah. This CardioNerds Atrial Fibrillation series is a multi-institutional collaboration made possible by contributions of stellar fellow leads and expert faculty from several programs, led by series co-chairs, Dr. Kelly Arps and Dr. Colin Blumenthal. This series is supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds. We have collaborated with VCU Health to provide CME. Claim free CME here! Disclosures: Dr. Ellis discloses grant or research support from Boston Scientific, Abbott-St Jude, advisor for Atricure and Medtronic. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls and Quotes - Atrial Fibrillation: Mechanical Stroke Prevention in Atrial fibrillation Surgical or catheter based left atrial appendage occlusion results in mechanical exclusion of the left atrial appendage, which is the most common source of thrombus leading to embolic events in patients with non-rheumatic atrial fibrillation. Surgical LAAO should be considered in patients with atrial fibrillation and CHA2DS2VASC score ≥ 2 undergoing cardiac surgery for other indications. Endocardial LAAO devices such as WATCHMAN FLX and AMULET are approved for stroke prevention in patients with atrial fibrillation with a CHA2DS2VASC score ≥ 2 and have an appropriate reason to seek a non-drug alternative to anticoagulation therapy. Appropriate patient selection and post-operative anticoagulation and imaging strategy are crucial for prevention and management of complications related to LAAO. Notes - Atrial Fibrillation: Mechanical Stroke Prevention in Atrial fibrillation What are the types of LAAO device? Left atrial appendage occlusion devices can be divided into epicardial closure and endocardial closure. Epicardial techniques/devices include surgical ligation, Atriclip, and Lariat. These techniques require pericardial access (either by open thoracotomy or thoracoscopic access). The goals are complete exclusion and ischemic necrosis of the LAA. LARIAT device Atriclip device Endocardial techniques include WATCHMAN FLX and AMULET devices. These techniques require the use of nitinol-based devices which are delivered into the LAA via a transeptal approach. These devices become endothelialized over time resulting in occlusion of the LAA. AMULET device WATCHMAN FLX Who is the ideal candidate for surgical LAAO? Several studies have evaluated the efficacy of surgical LAA occlusion. The most prominent being the LAOS III trial which randomized 4770 patients with atrial fibrillation and CHA2DS2VASC ≥ 2 undergoing cardiac surgery for other reasons to surgical LAAO vs no LAAO (3,4). The primary outcome of ischemic stroke or systemic embolization occurred in 4.8% of patients in the LAAO group vs 7% of patients in control group over an average ...